Novel Optical Resolution Technologies
Contributor(s): Sakai, Kenichi [editor.] | Hirayama, Noriaki [editor.] | Tamura, Rui [editor.] | SpringerLink (Online service).
Material type:
BookSeries: Topics in Current Chemistry: 269Publisher: Berlin, Heidelberg : Springer Berlin Heidelberg : Imprint: Springer, 2007.Description: XIV, 313 p. online resource.Content type: text Media type: computer Carrier type: online resourceISBN: 9783540463207.Other title: With contributions by numerous experts.Subject(s): Chemistry | Organic chemistry | Medicinal chemistry | Chemistry | Organic Chemistry | Medicinal ChemistryDDC classification: 547 Online resources: Click here to access online
Contents:
In:
Springer eBooks
Preferential Crystallization -- Mechanism and Scope of Preferential Enrichment, a Symmetry-Breaking Enantiomeric Resolution Phenomenon -- Racemization, Optical Resolution and Crystallization-Induced Asymmetric Transformation of Amino Acids and Pharmaceutical Intermediates -- Advantages of Structural Similaritiesof the Reactants in Optical Resolution Processes -- Dutch Resolution of Racemates and the Roles of Solid Solution Formation and Nucleation Inhibition -- New Resolution Technologies Controlled by Chiral Discrimination Mechanisms -- Molecular Mechanisms of Dielectrically Controlled Resolution (DCR) -- From Racemates to Single Enantiomers – Chiral Synthetic Drugs over the last 20 Years.
| Item type | Current location | Call number | Status | Date due | Barcode | Item holds |
|---|---|---|---|---|---|---|
E books
|
PK Kelkar Library, IIT Kanpur | Available | EBK9619 |
Total holds: 0
Preferential Crystallization -- Mechanism and Scope of Preferential Enrichment, a Symmetry-Breaking Enantiomeric Resolution Phenomenon -- Racemization, Optical Resolution and Crystallization-Induced Asymmetric Transformation of Amino Acids and Pharmaceutical Intermediates -- Advantages of Structural Similaritiesof the Reactants in Optical Resolution Processes -- Dutch Resolution of Racemates and the Roles of Solid Solution Formation and Nucleation Inhibition -- New Resolution Technologies Controlled by Chiral Discrimination Mechanisms -- Molecular Mechanisms of Dielectrically Controlled Resolution (DCR) -- From Racemates to Single Enantiomers – Chiral Synthetic Drugs over the last 20 Years.
There are no comments for this item.